D. Dunbabin

发表

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Cost-Effective Intervention in Stroke

D. Dunbabin, Dr David Dunbabin, 1992, PharmacoEconomics.

Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.

C. Sudlow, G. Hankey, D. Dunbabin, 2000, Stroke.

Antiplatelet therapy in the treatment and prevention of vascular disease: some clear answers, some new questions.

P. Sandercock, D. Dunbabin, A. T. Collaboration, 1994, Platelets.

Investigation of acute stroke: what is the most effective strategy?

P. Sandercock, D. Dunbabin, Peter Sandercock, 1991, Postgraduate medical journal.

Aspirin, warfarin, and recurrent stroke

P. Sandercock, D. Dunbabin, 1991, The Lancet.

Preventing Stroke by the Modification of Risk Factors

P. Sandercock, D. Dunbabin, Peter Sandercock, 1990, Stroke.

Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

C. Sudlow, G. Hankey, D. Dunbabin, 2000, The Cochrane database of systematic reviews.

Prophylaxis against Deep Venous Thrombosis and Pulmonary Embolism in Patients with Stroke

D. Dunbabin, 1996, Vascular medicine.

Correlation between functional and electrophysiological recovery in acute ischemic stroke.

David Kilpatrick, D. Kilpatrick, D. Dunbabin, 1999, Stroke.